Revenue: The sum of all revenue fields included for a company's operating activities.
Kymera Therapeutics, Inc. (KYMR) had Revenue of $47.07M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$47.07M |
$-223.86M |
|
-- |
|
$47.07M |
|
$308.71M |
|
$-261.63M |
|
$37.78M |
|
$-223.86M |
|
$-223.86M |
|
$-223.86M |
|
$-223.86M |
|
$-223.86M |
|
$-223.86M |
|
$-261.63M |
|
$-268.25M |
|
75.04M |
|
75.04M |
|
$-2.98 |
|
$-2.98 |
|
| Balance Sheet Financials | |
$510.27M |
|
$50.46M |
|
$467.77M |
|
$978.03M |
|
$67.77M |
|
$2.23M |
|
$74.65M |
|
$142.42M |
|
$835.62M |
|
$835.62M |
|
$835.62M |
|
64.89M |
|
| Cash Flow Statement Financials | |
$-194.50M |
|
$-404.08M |
|
$608.85M |
|
$115.78M |
|
$126.05M |
|
$10.27M |
|
$55.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.53 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-555.82% |
|
-555.82% |
|
-569.86% |
|
-475.57% |
|
-475.57% |
|
$-207.34M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-26.79% |
|
-26.79% |
|
-22.89% |
|
-26.72% |
|
$12.88 |
|
$-2.76 |
|
$-2.59 |
|